Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accreted, aggressive, alleviated, Axel, Cervarix, Cervarix®were, cervical, consecutive, covenanted, daily, drawdown, dusquetide, Ebola, eighty, Excellence, Farmaceutiche, footnote, formula, Garcea, Hawaii, HBI, HPV, ideal, ImmunoCellular, imputed, indemnification, John, Journal, Kingsbrook, Kodiak, Lehrer, LP, Maria, Master, Onexeo, online, OrbeShield®and, OrbeShield®in, particle, prevailing, promissory, promulgated, proof, protocol, Randolph, Riunite, River, scalable, SECURITIESE, Seed, sophisticated, SPORE, Subtopic, ThermoVax®development, ThermoVax®indicate, ThermoVax®technology, transparency, trend, tumor, USA, vesicular, visit, VLP, weekly, whatsoever
Removed:
abthrax, adapt, Adsorbed, ago, Anthim, apparent, AVA, Bavarian, BioThrax, blocking, bloodstream, cancelled, cellular, collaborating, compatible, confirmatory, conformational, consultant, continuing, culture, cytoplasm, discontinued, DNI, dominant, dormant, double, DSMB, durable, Dynavax, efficiently, endosomal, enhancing, environmentally, Evan, exceptionally, expiring, extending, extension, fewest, filtrate, germinate, glassification, globulin, headcount, hope, Horgan, impede, inhalation, inhalational, intradermal, intramuscular, Kevin, lie, Medarex, membrane, mutant, neutralize, newer, Nordic, onset, optioned, orBec, overwhelming, Pfenex, plasma, point, potency, predetermined, Principally, processing, progressing, prompted, prophylactic, recommendation, Recording, reexamination, reissue, releasing, rPA, safer, shock, smallpox, step, stockpiled, stopped, substitution, synthesize, thereof, toxemia, trafficking, translocation, transmitted, transported, typical, ungerminated, unstable, vaccinate, Valortim, vegetative, velothrax™, vial
Filing tables
Filing exhibits
- 10-K Annual report
- 10.31 Purchase Agreement Dated As of March 22, 2016 Between the Company and Lincoln Park Capital Fund, LLC.
- 10.32 Registration Rights Agreement Dated As of March 22, 2016 Between the Company and Lincoln Park Capital Fund, LLC.
- 21.1 Subsidiaries of the Company
- 23.1 Consent of Eisneramper LLP.
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
SNGX similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Soligenix, Inc. on Form S-8 (Nos. 333-130801, 333-196941 and 333-208515) of our report dated March 24, 2016, on our audits of the consolidated financial statements as of December 31, 2015 and 2014 and for each of the years then ended, which report is included in this Annual Report on Form 10-K to be filed on or about March 24, 2016.
/s/ EisnerAmper LLP
Philadelphia, Pennsylvania
March 24, 2016